112 related articles for article (PubMed ID: 3446908)
21. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin.
Kudo M; Todo A; Ikekubo K; Yamamoto K; Vera DR; Stadalnik RC
Hepatology; 1993 May; 17(5):814-9. PubMed ID: 8491449
[TBL] [Abstract][Full Text] [Related]
22. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
Int J Rad Appl Instrum B; 1991; 18(7):663-6. PubMed ID: 1787074
[TBL] [Abstract][Full Text] [Related]
23. [Estimation of total liver uptake and liver uptake per unit of liver volume of Tc-99m(Sn)-N-pyridoxyl-5-methyltryptophan (Tc-99m-PMT) using SPECT].
Nakamura K; Maeda H; Nakagawa T; Sakuma H; Kitano T; Takeda K; Yamaguchi N
Kaku Igaku; 1988 Dec; 25(12):1363-9. PubMed ID: 3266887
[No Abstract] [Full Text] [Related]
24. [Evaluation of hepatic function by hepatobiliary scintigraphy using factor analysis].
Shimomura O; Takahashi M; Tsuji A; Takagi Y; Tomiguchi S; Koga Y; Kojima A; Matsumoto M; Hara M; Hirota Y
Kaku Igaku; 1989 Feb; 26(2):145-53. PubMed ID: 2733200
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of usefulness of Tc-99m-GSA liver scintigraphy in chronic liver diseases].
Fukui H; Kashiwagi T; Kasahara A; Hiramatsu N; Matsunaga T; Oshita M; Goto M; Takei Y; Hayashi N; Kawano S
Kaku Igaku; 1991 Nov; 28(11):1333-41. PubMed ID: 1770648
[TBL] [Abstract][Full Text] [Related]
26. [In vivo measurement of hepatic binding protein in chronic liver disease--validation as a measure of hepatic functional reserve].
Kudo M; Vera DR; Stadalnik RC; Trudeau WL; Ikekubo K; Todo A
Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):40-50. PubMed ID: 1851238
[TBL] [Abstract][Full Text] [Related]
27. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage.
Kudo M; Todo A; Ikekubo K; Hino M
Am J Gastroenterol; 1992 Jul; 87(7):865-70. PubMed ID: 1615940
[TBL] [Abstract][Full Text] [Related]
28. [Hepatic receptor imaging with Tc-99m GSA: estimates of liver function in acute liver disease].
Kudo M; Ikekubo K; Todo A; Mimura J; Okabe Y; Kashida H; Hirasa M; Ibuki Y; Tomita S; Komori H
Nihon Shokakibyo Gakkai Zasshi; 1992 Mar; 89(3):616-26. PubMed ID: 1578806
[TBL] [Abstract][Full Text] [Related]
29. Tc-NGA imaging in liver transplantation: preliminary clinical experience.
Woodle ES; Ward RE; Stadalnik RC; Vera DR
Surgery; 1989 Mar; 105(3):401-7. PubMed ID: 2646744
[TBL] [Abstract][Full Text] [Related]
30. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
[TBL] [Abstract][Full Text] [Related]
31. [A new method for pharmacokinetic analysis of 99mTc-GSA using two-compartment and two-parameter model].
Nomura Y; Yamasaki K; Sakamoto S; Hayasi N; Hosaka K; Fukusima K; Sugimura K; Sakai H; Nagai H
Kaku Igaku; 2000 Nov; 37(6):631-8. PubMed ID: 11193448
[TBL] [Abstract][Full Text] [Related]
32. [The preparation of hepatic receptor imaging agent 99mTc-DTPA-NGA].
Li Y; Guan C; Wang Q
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):54-8. PubMed ID: 9208621
[TBL] [Abstract][Full Text] [Related]
33. 99mTc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of plasma and hepatic clearance for assessment of hepatic parenchyma performance.
Frieske I; Surma MJ; Bieńkiewicz M; Białkowska-Warzecha J; Liniecki J; Kuydowicz J; Kuśmierek J
Nucl Med Rev Cent East Eur; 2003; 6(1):23-8. PubMed ID: 14600929
[TBL] [Abstract][Full Text] [Related]
34. Relationship between (99m)Tc-GSA scintigraphic indices of liver function reserve and portal circulation in patients with chronic liver disease.
Osada H; Honda N; Takahashi T; Oku S; Abe A; Watanabe W; Okada T; Ohno H; Hondo M; Nishimura K
Ann Nucl Med; 2007 Jul; 21(5):245-9. PubMed ID: 17634841
[TBL] [Abstract][Full Text] [Related]
35. Assessment of hepatic excretory function in chronic liver disease by hepatobiliary scintigraphy.
Itoh H; Takahashi N; Shimono R; Sugawara T; Kawamura M; Tsuda T; Kataoka M; Iio A; Hamamoto K; Ohshima K
Ann Nucl Med; 1989 Nov; 3(3):139-42. PubMed ID: 2641459
[TBL] [Abstract][Full Text] [Related]
36. Hepatobiliary scintigraphy as a liver function test.
Heyman S
J Nucl Med; 1994 Mar; 35(3):436-7. PubMed ID: 8113891
[No Abstract] [Full Text] [Related]
37. [Phase III multi-center clinical study on 99mTc-GSA, a new agent for functional imaging of the liver].
Torizuka K; Ha-Kawa SK; Kudo M; Kubota Y; Yamamoto K; Itoh K; Nagao K; Uchiyama G; Koizumi K; Sasaki Y
Kaku Igaku; 1992 Feb; 29(2):159-81. PubMed ID: 1564788
[TBL] [Abstract][Full Text] [Related]
38. Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin.
Kurtaran A; Müller C; Novacek G; Kaserer K; Mentes M; Raderer M; Pidlich J; Eibenberger K; Angelberger P; Virgolini I
J Nucl Med; 1997 Dec; 38(12):1912-5. PubMed ID: 9430468
[TBL] [Abstract][Full Text] [Related]
39. [Clinical utility of receptor imaging in the assessment of liver function].
Kudo M; Ikekubo K; Todo A; Mimura J; Okabe Y; Kashida H; Hirasa M; Ibuki Y; Tomita S; Komori H
Nihon Shokakibyo Gakkai Zasshi; 1992 Jun; 89(6):1349-59. PubMed ID: 1501370
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance of a receptor-binding radiopharmacokinetic model.
Vera DR; Stadalnik RC; Metz CE; Pimstone NR
J Nucl Med; 1996 Jan; 37(1):160-4. PubMed ID: 8543988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
